Dr. James Tseng, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1972 Mesquite Ave, Lake Havasu City, AZ 86403 Phone: 288-546-5009 Fax: 928-854-6206 |
Abedon Abe Saiz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 90 Riviera Dr, Lake Havasu City, AZ 86403 Phone: 928-453-2900 Fax: 877-864-6566 |
Dr. Alexander Zilberman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1810 Mesquite Ave, Suite B, Lake Havasu City, AZ 86403 Phone: 928-854-6500 Fax: 928-854-6206 |
News Archive
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.
Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.
Type 1 (juvenile) diabetes and celiac disease appear to share a common genetic origin, scientists at the University of Cambridge and Barts and The London School of Medicine and Dentistry, have confirmed.
BioMimetic Therapeutics, Inc. today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA. The Company previously announced the filing of both the pre-clinical pharmacology/toxicology and quality/manufacturing modules with the FDA in June of 2009.
› Verified 6 days ago